A study published in JAMA Ophthalmology showed further evidence linking the predictive nature of high-sensitivity C-reactive protein in risk of age-related macular degeneration.
Ophthalmology
Post-operative cataract patients treated with Loteprednol etabonate as a gel or vehicle four times a day for two weeks saw significant reduction in pain and inflammation, according to a study published in the Journal of Cataract & Refractive Surgery.
San Antonio Eye Center in Texas opened a new 6,000-square-foot location in the city, culminating a two year renovation project to convert the facility from a historical home, according to a news release.
Elmhurst (Ill.) Outpatient Surgery Center announced in a news release they are the state's first outpatient surgery facility to offer Catalys Precision Laser System treatments for cataract and astigmatic procedures.
Three ophthalmologists of the Eye Clinic of Texas have been named "Best Doctors" in a peer survey that rates them in the top 5 percent of U.S. physicians, according to a news release.
Advertisement
Federal investigators are looking into an exceedingly high rate of Lucentis prescriptions and procedures performed by Salomon Melgen, MD, the West Palm, Fla., ophthalmologist who is tied up in political scandal with Sen. Robert Menendez (D-N.J.), according to a report…
Japanese researchers authored a study in the Journal of American Ophthalmology showing reduced-fluence photodynamic monotherapy for polypoidal choroidal vasculopathy patients improved and maintained visual acuity over two years.
Carnosic acid, a chemical found in the herb rosemary, has shown promising effects on protecting retinal cells against oxidation thanks to its antioxidant and anti-inflammatory activity, according to a study published in the medical journal Investigative Ophthalmology and Visual Science.
LASIK surgery to correct compound myopic astigmatism with high cylinder was safe and effective when performed using a fast-repetition-rate excimer laser with optimized aspheric profiles and cyclotorsion control, according to a study in the Journal of Cataract and Refractive Surgery.
After the FDA approved the use of JETREA injections to treat vitreomacular adhesion last October, Los Angeles-based Retina-Vitreous Associates Medical Group claims it is the first on the West Coast to use the drug to treat VMA patients non-surgically.